Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Nastasi, Claudia ^a   Fredholm, Simon ^a   Willerslev Olsen, Andreas ^a   Hansen, Morten ^b   Bonefeld, Charlotte Menné ^a   Geisler, Carsten ^a   Andersen, Mads Hald ^a,b   Ødum, Niels ^a   Woetmann, Anders ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE; IMMUNOLOGIC FACTOR; INTERLEUKIN 12; INTERLEUKIN 23; MELAN A; PROPIONIC ACID DERIVATIVE;

CD8+ T LYMPHOCYTE; CELL CULTURE; COCULTURE; DENDRITIC CELL; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM;

BUTYRATES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-12; INTERLEUKIN-23; MART-1 ANTIGEN; PROPIONATES;

EID: 85032935008     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-15099-w     Document Type: Article

References (53)

1. Lee, Y. K. & Mazmanian, S. K. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330, 1768-1773, https://doi.org/10.1126/science.1195568 (2010).
2. Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270, https://doi.org/10.1016/j.cell.2012.01.035 (2012).
3. Krautkramer, K. A. et al. Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues. Mol Cell 64, 982-992, https://doi.org/10.1016/j.molcel.2016.10.025 (2016).
4. den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54, 2325-2340, https://doi.org/10.1194/jlr.R036012 (2013).
5. Pomare, E. W., Branch, W. J. & Cummings, J. H. Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J Clin Invest 75, 1448-1454, https://doi.org/10.1172/JCI111847 (1985).
6. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-1227 (1987).
7. Bergman, E. N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70, 567-590 (1990).
8. Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12, 661-672, https://doi.org/10.1038/nrmicro3344 (2014).
9. Natarajan, N. & Pluznick, J. L. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol 307, C979-985, https://doi.org/10.1152/ajpcell.00228.2014 (2014).
10. Brown, A. J. et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278, 11312-11319, https://doi.org/10.1074/jbc.M211609200 (2003).
11. Le Poul, E. et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278, 25481-25489, https://doi.org/10.1074/jbc.M301403200 (2003).
12. Macia, L. et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6, 6734, https://doi.org/10.1038/ncomms7734 (2015).
13. Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111, 2247-2252, https://doi.org/10.1073/pnas.1322269111 (2014).
14. Waldecker, M., Kautenburger, T., Daumann, H., Busch, C. & Schrenk, D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 19, 587-593, https://doi.org/10.1016/j. jnutbio.2007.08.002 (2008).
15. Brestoff, J. R. & Artis, D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14, 676-684, https://doi.org/10.1038/ni.2640 (2013).
16. Kuwahara, A. Contributions of colonic short-chain Fatty Acid receptors in energy homeostasis. Front Endocrinol (Lausanne) 5, 144, https://doi.org/10.3389/fendo.2014.00144 (2014).
17. Thorburn, A. N., Macia, L. & Mackay, C. R. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 40, 833-842, https://doi.org/10.1016/j.immuni.2014.05.014 (2014).
18. Correa-Oliveira, R., Fachi, J. L., Vieira, A., Sato, F. T. & Vinolo, M. A. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology 5, e73, https://doi.org/10.1038/cti.2016.17 (2016).
19. Nastasi, C. et al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep 5, 16148, https://doi.org/10.1038/srep16148 (2015).
20. Dudek, A. M., Martin, S., Garg, A. D. & Agostinis, P. Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DCCancer Cells Interface That Augments Anticancer Immunity. Front Immunol 4, 438, https://doi.org/10.3389/fimmu.2013.00438 (2013).
21. Summers deLuca, L. & Gommerman, J. L. Fine-tuning of dendritic cell biology by the TNF superfamily. Nat Rev Immunol 12, 339-351, https://doi.org/10.1038/nri3193 (2012).
22. Blanco, P., Palucka, A. K., Pascual, V. & Banchereau, J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19, 41-52, https://doi.org/10.1016/j.cytogfr.2007.10.004 (2008).
23. Mildner, A. & Jung, S. Development and function of dendritic cell subsets. Immunity 40, 642-656, https://doi.org/10.1016/j. immuni.2014.04.016 (2014).
24. Randolph, G. J., Jakubzick, C. & Qu, C. Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol 20, 52-60, https://doi.org/10.1016/j.coi.2007.10.010 (2008).
25. Kratky, W., Reis e Sousa, C., Oxenius, A. & Sporri, R. Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination. Proc Natl Acad Sci USA 108, 17414-17419, https://doi.org/10.1073/pnas.1108945108 (2011).
26. Hubo, M. et al. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol 4, 82, https://doi.org/10.3389/fimmu.2013.00082 (2013).
27. Mempel, T. R., Henrickson, S. E. & Von Andrian, U. H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154-159, https://doi.org/10.1038/nature02238 (2004).
28. Schmidt, C. S. & Mescher, M. F. Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-12. The Journal of Immunology 168, 5521-5529, https://doi.org/10.4049/jimmunol.168.11.5521 (2002).
29. Schurich, A. et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog 9, e1003208, https://doi.org/10.1371/journal.ppat.1003208 (2013).
30. Curtsinger, J. M. et al. Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells. J Immunol 162, 3256-3262 (1999).
31. Pittet, M. J. et al. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 190, 705-715 (1999).
32. Coulie, P. G. et al. Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer 50, 289-297 (1992).
33. Soares, A. et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. Journal of Immunological Methods 362, 43-50, https://doi.org/10.1016/j.jim.2010.08.007 (2010).
34. Henry, C. J., Ornelles, D. A., Mitchell, L. M., Brzoza-Lewis, K. L. & Hiltbold, E. M. IL-12 produced by dendritic cells augments CD8 + T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 181, 8576-8584 (2008).
35. Sharon, G. et al. Specialized metabolites from the microbiome in health and disease. Cell Metab 20, 719-730, https://doi.org/10.1016/j.cmet.2014.10.016 (2014).
36. Lu, Y. et al. Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota. Sci Rep 6, 37589, https://doi.org/10.1038/srep37589 (2016).
37. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9, 313-323, https://doi.org/10.1038/nri2515 (2009).
38. Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573, https://doi.org/10.1126/science.1241165 (2013).
39. Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20, 159-166, https://doi.org/10.1038/nm.3444 (2014).
40. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455, https://doi.org/10.1038/nature12726 (2013).
41. Ciarlo, E. et al. Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo. Sci Rep 6, 37944, https://doi.org/10.1038/srep37944 (2016).
42. Haghikia, A. et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity 43, 817-829, https://doi.org/10.1016/j.immuni.2015.09.007 (2015).
43. Pufnock, J. S. et al. Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28. Blood 117, 6542-6551, https://doi.org/10.1182/blood-2010-11-317966 (2011).
44. Linsley, P. S. et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173, 721-730 (1991).
45. Jonuleit, H. et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27, 3135-3142, https://doi.org/10.1002/eji.1830271209 (1997).
46. MacDonald, A. S. et al. Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40/CD154 interaction. J Immunol 168, 4643-4649 (2002).
47. Lapteva, N. et al. Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation. Cancer Res 67, 10528-10537, https://doi.org/10.1158/0008-5472.CAN-07-0833 (2007).
48. Haenssle, H. et al. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes. Exp Dermatol 17, 177-187, https://doi.org/10.1111/j.1600-0625.2007.00668.x (2008).
49. Prechtel, A. T., Turza, N. M., Theodoridis, A. A. & Steinkasserer, A. CD83 Knockdown in Monocyte-Derived Dendritic Cells by Small Interfering RNA Leads to a Diminished T Cell Stimulation. The Journal of Immunology 178, 5454-5464, https://doi.org/10.4049/jimmunol.178.9.5454 (2007).
50. Aerts-Toegaert, C. et al. CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37, 686-695, https://doi.org/10.1002/eji.200636535 (2007).
51. Cao, W., Lee, S. H. & Lu, J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J 385, 85-93, https://doi.org/10.1042/BJ20040741 (2005).
52. Kruse, M. et al. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J Exp Med 191, 1581-1590 (2000).
53. Wolfl, M. & Greenberg, P. D. Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat Protoc 9, 950-966, https://doi.org/10.1038/nprot.2014.064 (2014).